Targeting CYP450 modulation to decrease the risk of induced cataract in the experimental model

BACKGROUND: Diabetes is one of the major causes of cataract. Some drugs prescribed for the treatment of diabetes are the modulators of CYP450, which may alter the risk of cataract. OBJECTIVE: To study the effect of CYP450 modulation in galactosemic cataract. MATERIALS AND METHODS: Male Sprague-Dawle...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, D V, Gandhi, T R, Patel, K V, Patil, D B, Parikh, P V
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993975/
https://www.ncbi.nlm.nih.gov/pubmed/20952829
http://dx.doi.org/10.4103/0301-4738.71676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993975/
https://www.ncbi.nlm.nih.gov/pubmed/20952829
http://dx.doi.org/10.4103/0301-4738.71676

Ejemplares similares